Profound Medical (PROF) Gains from Investment Securities (2022 - 2026)
Profound Medical (PROF) recorded quarterly Gains from Investment Securities of $25000.0 in Q1 2026, down 98.83% quarter-over-quarter from $2.1 million in Q4 2025, and up 247.22% on a YoY basis from $7200.0 in Q1 2025.
Profound Medical (PROF) Gains from Investment Securities (2022 - 2026) Analysis & Trends
Profound Medical's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 247.22% year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $237000.0 (up 3191.67% YoY), while the FY2025 annual figure was $2.1 million, down 6.49% from the prior year.
- Gains from Investment Securities was $25000.0 for Q1 2026 at Profound Medical, down from $2.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.3 million in Q4 2024 to a low of $7200.0 in Q1 2025.
- Historically, Gains from Investment Securities has averaged $723011.7 across 5 years, with a median of $160000.0 in 2024.
- Biggest YoY gain for Gains from Investment Securities was 517.3% in 2025; the steepest drop was 66.19% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $1.5 million in 2022, then declined by 2.45% to $1.5 million in 2023, then soared by 55.35% to $2.3 million in 2024, then slipped by 6.49% to $2.1 million in 2025, then slumped by 98.83% to $25000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $25000.0 (Q1 2026), $2.1 million (Q4 2025), and $234573.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Profound Medical | 240.29 Mn | 190.00 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 234,573.00 |
| Sep 30, 2025 | 234,573.00 |
| Jun 30, 2025 | 54,100.00 |
| Jun 30, 2025 | 54,100.00 |
| Mar 31, 2025 | 7,200.00 |
| Mar 31, 2025 | 7,200.00 |
| Dec 31, 2024 | 2.29 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |